Medicare Enrolled

Dr. Vinay Reddy, MD

Rheumatology · Venice, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
411 COMMERCIAL CT STE C, Venice, FL 34292
8133335080
Registered in NPPES since 2005
NPI: 1275535536 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reddy

Dr. Vinay Reddy is a rheumatology specialist in Venice, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 111,332 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Reddy received a total of $62,218 from 59 pharmaceutical and/or device companies across 1670 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 23% volume in FL $62,218 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 172397 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
111,332
Medicare services
Top 23% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
72,400 $4 $11
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
26,225 $33 $85
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
9,250 $10 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,111 $56 $184
Autoimmune disorder antibody test
A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders.
434 $17 $50
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
425 $87 $345
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
398 $50 $189
Immunoassay substance analysis, multiple step method
A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material.
172 $11 $32
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
113 $29 $80
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
93 $113 $415
Rheumatoid arthritis antibody test
A blood test to measure antibodies used in assessing rheumatoid arthritis.
90 $13 $36
Rheumatoid factor level 89 $6 $40
Tuberculosis blood test (gamma interferon)
A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels.
81 $60 $100
DNA antibody test (native or double-stranded)
A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body.
65 $13 $100
Measurement of dna antibody, single stranded 65 $12 $50
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
64 $91 $270
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
60 $9 $40
Injection, methylprednisolone acetate, 40 mg 49 $6 $30
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
42 $63 $273
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
40 $39 $145
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
39 $43 $175
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
27 $37 $110
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
32.2% high complexity
65.6% medium
2.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$62,218
Total received (2018-2024)
Avg $8,888/year across 7 years
Top 10% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,670
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,816
2023
$4,395
2022
$9,518
2021
$3,498
2020
$4,815
2019
$18,554
2018
$16,623

Payments by company (2024)

Amgen Inc.
$971
ABBVIE INC.
$843
Mallinckrodt Hospital Products Inc.
$397
ANI Pharmaceuticals, Inc.
$311
GENZYME CORPORATION
$266
GlaxoSmithKline, LLC.
$263
UCB, Inc.
$254
Novartis Pharmaceuticals Corporation
$237
E.R. Squibb & Sons, L.L.C.
$226
Janssen Biotech, Inc.
$224
PFIZER INC.
$178
Boston Scientific Corporation
$125
Fresenius Kabi USA, LLC
$120
Aurinia Pharma U.S., Inc.
$87
Lilly USA, LLC
$78
AstraZeneca Pharmaceuticals LP
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Genentech USA, Inc.
$40
Radius Health, Inc.
$37
Alexion Pharmaceuticals, Inc.
$37
SCILEX PHARMACEUTICALS INC.
$14
Top 3 companies account for 45.9% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$14,540
GENZYME CORPORATION
$9,782
Horizon Pharma plc
$9,300
Aurinia Pharma U.S., Inc.
$3,756
ABBVIE INC.
$2,738
Amgen Inc.
$2,603
Janssen Biotech, Inc.
$2,032
UCB, Inc.
$1,783
Mallinckrodt Hospital Products Inc.
$1,695
PFIZER INC.
$1,533
Novartis Pharmaceuticals Corporation
$1,395
E.R. Squibb & Sons, L.L.C.
$1,227
GlaxoSmithKline, LLC.
$1,167
AbbVie Inc.
$1,013
Mallinckrodt Enterprises LLC
$994
AbbVie, Inc.
$800
Lilly USA, LLC
$788
ANI Pharmaceuticals, Inc.
$683
Genentech USA, Inc.
$567
Exeltis, USA Inc.
$327
Boehringer Ingelheim Pharmaceuticals, Inc.
$319
MEDAC PHARMA, INC.
$278
Flexion Therapeutics, Inc.
$251
Celgene Corporation
$221
Antares Pharma, Inc.
$218
Actelion Pharmaceuticals US, Inc.
$198
AstraZeneca Pharmaceuticals LP
$197
Fresenius Kabi USA, LLC
$172
Radius Health, Inc.
$165
Mallinckrodt LLC
$147
Merck Sharp & Dohme Corporation
$147
Boston Scientific Corporation
$125
TerSera Therapeutics LLC
$102
Otsuka America Pharmaceutical, Inc.
$100
MEDEXUS PHARMA, INC.
$84
Alexion Pharmaceuticals, Inc.
$84
Pacira Therapeutics, Inc.
$72
Bioventus LLC
$69
SANOFI-AVENTIS U.S. LLC
$65
Organon LLC
$48
Hikma Pharmaceuticals USA
$48
Ultragenyx Pharmaceutical Inc.
$41
ASSERTIO THERAPEUTICS, Inc.
$38
DePuy Synthes Sales Inc.
$33
Sebela Pharmaceuticals Inc.
$32
Mission Pharmacal Company
$24
Midatech Pharma US Inc
$24
SOBI, INC
$22
Eisai Inc.
$21
West-Ward Pharmaceuticals
$18
Sandoz Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Orthogenrx Inc.
$17
Novo Nordisk Inc
$15
Purdue Pharma L.P.
$15
SCILEX PHARMACEUTICALS INC.
$14
Zyla Life Sciences, Inc.
$13
Ironwood Pharmaceuticals, Inc
$13
Daiichi Sankyo Inc.
$11
Top 3 companies account for 54.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Aquoral · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · DUZALLO · Dayvigo · Durolane · EVENITY · EVUSHELD · Enbrel · FLECTOR · FORTEO · Gralise · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · Morphabond ER · NO PRODUCT DISCUSSED · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · Otrexup · PANZYGA · PENNSAID · PURIFIED CORTROPHIN GEL · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RIDAURA · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAMSCA · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · SYMPROIC · TALTZ · TAVNEOS · TREMFYA · Tavneos · TriVisc sodium hyaluronate · Tymlos · ULTOMIRIS · UPTRAVI · Uloric · VIMOVO · VRAYLAR · Victoza · WATCHMAN Access System · XELJANZ · XYOSTED · ZTLido · Zilretta · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Venice?
Compare rheumatologists in the Venice area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
24
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
SARASOTA MEMORIAL HOSPITAL - VENICE
6.4 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Reddy experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Reddy performed 72,400 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $62,218 from 59 companies across 1,670 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other rheumatologists in Venice?
Dr. Reddy's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →